Mouse Mu-type Opioid Receptor,OPRM1 ELI

Receptor for endogenous opioids such as beta-endorphin and endomorphin.

Receptor for natural and synthetic opioids including morphine, heroin, DAMGO, fentanyl, etorphine, buprenorphin and methadone.

Agonist binding to the receptor induces coupling to an inactive GDP-bound heterotrimeric G-protein complex and subsequent exchange of GDP for GTP in the G-protein alpha subunit leading to dissociation of the G-protein complex with the free GTP-bound G-protein alpha and the G-protein beta-gamma dimer activating downstream cellular effectors.

The agonist- and cell type-specific activity is predominantly coupled to pertussis toxin-sensitive G(i) and G(o) G alpha proteins, GNAI1, GNAI2, GNAI3 and GNAO1 isoforms Alpha-1 and Alpha-2, and to a lesser extent to pertussis toxin-insensitive G alpha proteins GNAZ and GNA15.

They mediate an array of downstream cellular responses, including inhibition of adenylate cyclase activity and both N-type and L-type calcium channels, activation of inward rectifying potassium channels, mitogen-activated protein kinase (MAPK), phospholipase C (PLC), phosphoinositide/protein kinase (PKC), phosphoinositide 3-kinase (PI3K) and regulation of NF-kappa-B.

Also couples to adenylate cyclase stimulatory G alpha proteins.

The selective temporal coupling to G-proteins and subsequent signaling can be regulated by RGSZ proteins, such as RGS9, RGS17 and RGS4.

Phosphorylation by members of the GPRK subfamily of Ser/Thr protein kinases and association with beta-arrestins is involved in short-term receptor desensitization.

Beta-arrestins associate with the GPRK-phosphorylated receptor and uncouple it from the G-protein thus terminating signal transduction.

The phosphorylated receptor is internalized through endocytosis via clathrin-coated pits which involves beta-arrestins.

The activation of the ERK pathway occurs either in a G-protein-dependent or a beta-arrestin-dependent manner and is regulated by agonist-specific receptor phosphorylation.

Acts as a class A G-protein coupled receptor (GPCR) which dissociates from beta-arrestin at or near the plasma membrane and undergoes rapid recycling.

Receptor down-regulation pathways are varying with the agonist and occur dependent or independent of G-protein coupling.

Endogenous ligands induce rapid desensitization, endocytosis and recycling.

Heterooligomerization with other GPCRs can modulate agonist binding, signaling and trafficking properties.

Involved in neurogenesis.

Isoform 9 is involved in morphine-induced scratching and seems to cross-activate GRPR in response to morphine.

{ECO:0000269|PubMed:10842167, ECO:0000269|PubMed:16682964, ECO:0000269|PubMed:21422164, ECO:0000269|PubMed:22437502, ECO:0000269|PubMed:26245379, ECO:0000269|PubMed:7797593, ECO:0000269|PubMed:9037090}.